Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Inorg Biochem ; 159: 120-32, 2016 06.
Article in English | MEDLINE | ID: mdl-26986979

ABSTRACT

The complexes [Ag2(OOC-(CH2)n-COO)] (n=1-10) (1-10) were synthesised and reacted with 1,10-phenanthroline (phen) to yield derivatives formulating as [Ag2(phen)x(OOC-(CH2)y-COO)]·zH2O (x=2 or 3; y=1-10; z=1-4) (11-20) which are highly water-soluble and photo-stable in aqueous solution. The phen derivatives 11-20 exhibit chemotherapeutic potential against Candida albicans, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa and against cisplatin-sensitive breast (MCF-7) and resistant ovarian (SKOV-3) cancer cell lines. Cyclic voltammetric analysis and DNA binding and intercalation studies indicate that the mechanism of action of 11-20 is significantly different to that of their silver(I) dicarboxylate precursors and they do not induce DNA damage or ROS generation in mammalian cells. The representative complexes 9 and 19 (containing the undecanedioate ligand) were both found to significantly reduce superoxide and hydrogen peroxide induced oxidative stress in the yeast S. cerevisiae.


Subject(s)
Anti-Infective Agents , Antineoplastic Agents , Bacteria/growth & development , Breast Neoplasms/drug therapy , Candida albicans/growth & development , Ovarian Neoplasms/drug therapy , Phenanthrolines , Silver , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Female , Humans , Intercalating Agents/chemical synthesis , Intercalating Agents/chemistry , Intercalating Agents/pharmacology , MCF-7 Cells , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Phenanthrolines/chemical synthesis , Phenanthrolines/chemistry , Phenanthrolines/pharmacology , Saccharomyces cerevisiae/metabolism , Silver/chemistry , Silver/pharmacology , Solubility
2.
Free Radic Biol Med ; 80: 67-76, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25511255

ABSTRACT

Due to their aerobic lifestyle, eukaryotic organisms have evolved different strategies to overcome oxidative stress. The recruitment of some specific metalloenzymes such as superoxide dismutases (SODs) and catalases (CATs) is of great importance for eliminating harmful reactive oxygen species (hydrogen peroxide and superoxide anion). Using the ligand HPClNOL {1-[bis(pyridin-2-ylmethyl)amino]-3-chloropropan-2-ol}, we have synthesized three coordination compounds containing iron(III), copper(II), and manganese(II) ions, which are also present in the active site of the above-noted metalloenzymes. These compounds were evaluated as SOD and CAT mimetics. The manganese and iron compounds showed both SOD and CAT activities, while copper showed only SOD activity. The copper and manganese in vitro SOD activities are very similar (IC50~0.4 µmol dm(-3)) and about 70-fold higher than those of iron. The manganese compound showed CAT activity higher than that of the iron species. Analyzing their capacity to protect Saccharomyces cerevisiae cells against oxidative stress (H2O2 and the O2(•-) radical), we observed that all compounds act as antioxidants, increasing the resistance of yeast cells mainly due to a reduction of lipid oxidation. Especially for the iron compound, the data indicate complete protection when wild-type cells were exposed to H2O2 or O2(•-) species. Interestingly, these compounds also compensate for both superoxide dismutase and catalase deficiencies; their antioxidant activity is metal ion dependent, in the order iron(III)>copper(II)>manganese(II). The protection mechanism employed by the complexes proved to be independent of the activation of transcription factors (such as Yap1, Hsf1, Msn2/Msn4) and protein synthesis. There is no direct relation between the in vitro and the in vivo antioxidant activities.


Subject(s)
Antioxidants/pharmacology , Biomimetic Materials/pharmacology , Coordination Complexes/pharmacology , Copper/chemistry , Iron/chemistry , Manganese/chemistry , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae/drug effects , Antioxidants/chemical synthesis , Biocatalysis , Biomimetic Materials/chemical synthesis , Catalase/chemistry , Catalase/metabolism , Coordination Complexes/chemical synthesis , Gene Expression , Hydrogen Peroxide/antagonists & inhibitors , Hydrogen Peroxide/pharmacology , Lipid Peroxidation/drug effects , Microbial Viability/drug effects , Oxidative Stress/drug effects , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Superoxide Dismutase/chemistry , Superoxide Dismutase/metabolism , Superoxides/antagonists & inhibitors , Superoxides/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...